LPL Financial
MRVI icon

LPL Financial’s Maravai LifeSciences MRVI Stock Holding History

LPL Financial’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$32.4K Buy
+11,438
New +$38.8K ﹤0.01% 5828
2024
Q4 		– Sell
-35,173
Closed -$292K – 5393
2024
Q3 		$292K Buy
35,173
+8,759
+33% +$75.7K ﹤0.01% 4449
2024
Q2 		$189K Buy
26,414
+4,645
+21% +$40.1K ﹤0.01% 4588
2024
Q1 		$189K Buy
21,769
+593
+3% +$4.01K ﹤0.01% 4523
2023
Q4 		$139K Sell
21,176
-1,121
-5% -$7.24K ﹤0.01% 4484
2023
Q3 		$223K Buy
22,297
+1,145
+5% +$12.6K ﹤0.01% 4155
2023
Q2 		$263K Buy
21,152
+330
+2% +$4.45K ﹤0.01% 3960
2023
Q1 		$292K Buy
20,822
+7,899
+61% +$113K ﹤0.01% 3766
2022
Q4 		$185K Buy
12,923
+2,544
+25% +$40.1K ﹤0.01% 4017
2022
Q3 		$265K Buy
+10,379
New +$260K ﹤0.01% 3707
2022
Q1 		– Sell
-5,889
Closed -$247K – 4325
2021
Q4 		$247K Sell
5,889
-150
-2% -$6.08K ﹤0.01% 3836
2021
Q3 		$296K Sell
6,039
-921
-13% -$44.9K ﹤0.01% 3660
2021
Q2 		$290K Buy
+6,960
New +$270K ﹤0.01% 3614

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LPL Financial's MRVI Position: Q1 2026 in Review

LPL Financial opened a new position in Maravai LifeSciences (MRVI) in Q1 2026: 11,438 shares worth $32.4K. The stake represents ﹤0.01% of the portfolio and ranks #5828 among its holdings. This is a return to the name: LPL Financial previously reported a position in MRVI as recently as Q3 2024.

LPL Financial first reported a position in MRVI in Q2 2021 and has held it in 13 quarters since. The position peaked at $296K in Q3 2021. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

  • LPL Financial held 11,438 shares of Maravai LifeSciences worth $32.4K as of Q1 2026.
  • Maravai LifeSciences was a new LPL Financial position in Q1 2026.
  • Maravai LifeSciences made up ﹤0.01% of LPL Financial's portfolio in Q1 2026, its #5828 holding.
  • LPL Financial first reported a position in Maravai LifeSciences in Q2 2021 and has held it in 13 quarters since.
  • LPL Financial's Maravai LifeSciences position peaked at $296K in Q3 2021.
  • 158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.